Header Logo

Connection

Nirav Shah to Leukotriene Antagonists

Back to Details
This is a "connection" page, showing publications Nirav Shah has written about Leukotriene Antagonists.
Nirav Shah
Connection Strength
0.056
Leukotriene Antagonists
  1. Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial. JAMA Netw Open. 2024 10 01; 7(10):e2439332.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.